These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7994987)
21. Clinical manifestations and vascular events in patients with lupus erythematosus anticardiolipin antibodies and raynaud's phenomenon. Rodriguez VE; Gonzalez-Pares EN; Rivera C P R Health Sci J; 2006 Dec; 25(4):307-13. PubMed ID: 17550096 [TBL] [Abstract][Full Text] [Related]
22. Distribution of lupus anticoagulant and anticardiolipin antibody isotypes in a population with antiphospholipid syndrome. Guglielmone HA; Fernandez EJ J Rheumatol; 1999 Jan; 26(1):86-90. PubMed ID: 9918246 [TBL] [Abstract][Full Text] [Related]
23. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals. Al Jabri AA; Al Buloshi MS Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168 [TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibody positive young stroke: an analysis of 12 cases. Panagariya A; Garg A; Sureka RK J Postgrad Med; 2000; 46(4):258-61. PubMed ID: 11435651 [TBL] [Abstract][Full Text] [Related]
27. Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study. Tanne D; D'Olhaberriague L; Trivedi AM; Salowich-Palm L; Schultz LR; Levine SR Neuroepidemiology; 2002; 21(2):93-9. PubMed ID: 11901279 [TBL] [Abstract][Full Text] [Related]
28. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome. Levine SR; Brey RL; Sawaya KL; Salowich-Palm L; Kokkinos J; Kostrzema B; Perry M; Havstad S; Carey J Ann Neurol; 1995 Jul; 38(1):119-24. PubMed ID: 7611714 [TBL] [Abstract][Full Text] [Related]
29. IgM-anticardiolipin antibody and vascular access thrombosis in chronic hemodialysis patients. Chuang FR; Chen TC; Yang CC; Cheng YF; Hsu KT; Lee CH; Lin CL; Wang IK; Chang HW; Wang PH Ren Fail; 2005; 27(1):25-30. PubMed ID: 15717631 [TBL] [Abstract][Full Text] [Related]
30. Antiphospholipid antibodies in adults with immune thrombocytopenic purpura. Pierrot-Deseilligny Despujol C; Michel M; Khellaf M; Gouault M; Intrator L; Bierling P; Godeau B Br J Haematol; 2008 Aug; 142(4):638-43. PubMed ID: 18510681 [TBL] [Abstract][Full Text] [Related]
31. C-reactive protein level as a predictor of transient vs. sustained anticardiolipin antibody positivity. Twito O; Reshef T; Ellis MH Eur J Haematol; 2006 Mar; 76(3):206-9. PubMed ID: 16451395 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Shin DH; Lee PH; Bang OY Arch Neurol; 2005 Aug; 62(8):1232-7. PubMed ID: 16087764 [TBL] [Abstract][Full Text] [Related]
33. Significance of elevated IgG anticardiolipin antibody levels in patients with Budd-Chiari syndrome. Aggarwal R; Ravishankar B; Misra R; Aggarwal A; Dwivedi S; Naik SR Am J Gastroenterol; 1998 Jun; 93(6):954-7. PubMed ID: 9647027 [TBL] [Abstract][Full Text] [Related]
34. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Kawakami T; Watabe H; Mizoguchi M; Soma Y Br J Dermatol; 2006 Nov; 155(5):983-7. PubMed ID: 17034529 [TBL] [Abstract][Full Text] [Related]
35. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity]. Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265 [TBL] [Abstract][Full Text] [Related]
36. Elevated anticardiolipin antibody titer is a stroke risk factor in a multiethnic population independent of isotype or degree of positivity. Tuhrim S; Rand JH; Wu XX; Weinberger J; Horowitz DR; Goldman ME; Godbold JH Stroke; 1999 Aug; 30(8):1561-5. PubMed ID: 10436101 [TBL] [Abstract][Full Text] [Related]
37. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ginsburg KS; Liang MH; Newcomer L; Goldhaber SZ; Schur PH; Hennekens CH; Stampfer MJ Ann Intern Med; 1992 Dec; 117(12):997-1002. PubMed ID: 1443986 [TBL] [Abstract][Full Text] [Related]
38. Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases. D'Olhaberriague L; Levine SR; Salowich-Palm L; Tanne D; Sawaya KL; Aurora TK; Perry M; Day M; Spencer T; Schultz L Neurology; 1998 Nov; 51(5):1376-80. PubMed ID: 9818863 [TBL] [Abstract][Full Text] [Related]
39. Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study. Heinzlef O; Abuaf N; Cohen A; Amarenco P; J Neurol; 2001 May; 248(5):373-9. PubMed ID: 11437157 [TBL] [Abstract][Full Text] [Related]
40. Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and Västerbotten cohort project. Ahmed E; Stegmayr B; Trifunovic J; Weinehall L; Hallmans G; Lefvert AK Stroke; 2000 Jun; 31(6):1289-93. PubMed ID: 10835446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]